Cargando…

A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics

BACKGROUND: The proteomic analysis of body fluids is a growing technology for the identification of protein biomarkers of disease. Given that Papanicolaou tests (Pap tests) are routinely performed on over 30 million women annually in the U.S. to screen for cervical cancer, we examined the residual P...

Descripción completa

Detalles Bibliográficos
Autores principales: Boylan, Kristin LM, Afiuni-Zadeh, Somaieh, Geller, Melissa A, Hickey, Kayla, Griffin, Timothy J, Pambuccian, Stefan E, Skubitz, Amy PN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106909/
https://www.ncbi.nlm.nih.gov/pubmed/25097468
http://dx.doi.org/10.1186/1559-0275-11-30
_version_ 1782327553115029504
author Boylan, Kristin LM
Afiuni-Zadeh, Somaieh
Geller, Melissa A
Hickey, Kayla
Griffin, Timothy J
Pambuccian, Stefan E
Skubitz, Amy PN
author_facet Boylan, Kristin LM
Afiuni-Zadeh, Somaieh
Geller, Melissa A
Hickey, Kayla
Griffin, Timothy J
Pambuccian, Stefan E
Skubitz, Amy PN
author_sort Boylan, Kristin LM
collection PubMed
description BACKGROUND: The proteomic analysis of body fluids is a growing technology for the identification of protein biomarkers of disease. Given that Papanicolaou tests (Pap tests) are routinely performed on over 30 million women annually in the U.S. to screen for cervical cancer, we examined the residual Pap test fluid as a source of protein for analysis by mass spectrometry (MS). In the liquid-based Pap test, cervical cells are collected from the ectocervix and placed into an alcohol-based fixative prior to staining and pathologic examination. We hypothesized that proteins shed by cells of the female genital tract can be detected in the Pap test fixative by MS-based proteomic techniques. We examined the feasibility of using residual fluid from discarded Pap tests with cytologically “normal” results to optimize sample preparation for MS analysis. The protein composition of the cell-free Pap test fluid was determined by silver staining of sodium dodecyl sulfate -polyacrylamide gels, and the abundance of serum proteins was examined by Western immunoblot using an antibody against human serum albumin. Both pooled and individual samples were trypsin digested and analyzed by two-dimensional MS/MS. Proteins were identified by searching against the Human Uniprot database, and characterized for localization, function and relative abundance. RESULTS: The average volume of the residual Pap test fluid was 1.5 ml and the average protein concentration was 0.14 mg/ml. By Western immunoblot we showed that the amount of albumin in each sample was significantly reduced compared to normal serum. By MS/MS, we identified 714 unique proteins in pooled Pap test samples and an average of 431 proteins in individual samples. About 40% of the proteins identified were extracellular or localized to the plasma membrane. Almost 20% of the proteins identified were involved in immunity and defense, characteristic of the healthy cervical-vaginal proteome. By merging the protein sets from the individual and pooled Pap test samples, we created a “Normal Pap test Core Proteome” consisting of 153 proteins. CONCLUSIONS: Residual Pap test fluid contains a sufficient amount of protein for analysis by MS and represents a valuable biospecimen source for the identification of protein biomarkers for gynecological diseases.
format Online
Article
Text
id pubmed-4106909
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-41069092014-08-05 A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics Boylan, Kristin LM Afiuni-Zadeh, Somaieh Geller, Melissa A Hickey, Kayla Griffin, Timothy J Pambuccian, Stefan E Skubitz, Amy PN Clin Proteomics Research BACKGROUND: The proteomic analysis of body fluids is a growing technology for the identification of protein biomarkers of disease. Given that Papanicolaou tests (Pap tests) are routinely performed on over 30 million women annually in the U.S. to screen for cervical cancer, we examined the residual Pap test fluid as a source of protein for analysis by mass spectrometry (MS). In the liquid-based Pap test, cervical cells are collected from the ectocervix and placed into an alcohol-based fixative prior to staining and pathologic examination. We hypothesized that proteins shed by cells of the female genital tract can be detected in the Pap test fixative by MS-based proteomic techniques. We examined the feasibility of using residual fluid from discarded Pap tests with cytologically “normal” results to optimize sample preparation for MS analysis. The protein composition of the cell-free Pap test fluid was determined by silver staining of sodium dodecyl sulfate -polyacrylamide gels, and the abundance of serum proteins was examined by Western immunoblot using an antibody against human serum albumin. Both pooled and individual samples were trypsin digested and analyzed by two-dimensional MS/MS. Proteins were identified by searching against the Human Uniprot database, and characterized for localization, function and relative abundance. RESULTS: The average volume of the residual Pap test fluid was 1.5 ml and the average protein concentration was 0.14 mg/ml. By Western immunoblot we showed that the amount of albumin in each sample was significantly reduced compared to normal serum. By MS/MS, we identified 714 unique proteins in pooled Pap test samples and an average of 431 proteins in individual samples. About 40% of the proteins identified were extracellular or localized to the plasma membrane. Almost 20% of the proteins identified were involved in immunity and defense, characteristic of the healthy cervical-vaginal proteome. By merging the protein sets from the individual and pooled Pap test samples, we created a “Normal Pap test Core Proteome” consisting of 153 proteins. CONCLUSIONS: Residual Pap test fluid contains a sufficient amount of protein for analysis by MS and represents a valuable biospecimen source for the identification of protein biomarkers for gynecological diseases. Springer 2014-07-14 /pmc/articles/PMC4106909/ /pubmed/25097468 http://dx.doi.org/10.1186/1559-0275-11-30 Text en Copyright © 2014 Boylan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Boylan, Kristin LM
Afiuni-Zadeh, Somaieh
Geller, Melissa A
Hickey, Kayla
Griffin, Timothy J
Pambuccian, Stefan E
Skubitz, Amy PN
A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
title A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
title_full A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
title_fullStr A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
title_full_unstemmed A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
title_short A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
title_sort feasibility study to identify proteins in the residual pap test fluid of women with normal cytology by mass spectrometry-based proteomics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106909/
https://www.ncbi.nlm.nih.gov/pubmed/25097468
http://dx.doi.org/10.1186/1559-0275-11-30
work_keys_str_mv AT boylankristinlm afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT afiunizadehsomaieh afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT gellermelissaa afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT hickeykayla afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT griffintimothyj afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT pambuccianstefane afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT skubitzamypn afeasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT boylankristinlm feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT afiunizadehsomaieh feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT gellermelissaa feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT hickeykayla feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT griffintimothyj feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT pambuccianstefane feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics
AT skubitzamypn feasibilitystudytoidentifyproteinsintheresidualpaptestfluidofwomenwithnormalcytologybymassspectrometrybasedproteomics